
Tom Zielinski
Bellbrook Labs, USA
Title: Discovery of glycosyltransferase inhibitors of GALNT3 using the assay optimization and a transcreener UDP2 assay and orthogonal pooled screening
Biography
Tom Zielinski has worked at Bellbrook Labs for over 8 years where he is the Manager of Biochemical assays. Over 20 years, he has been an R&D Scientist who has helped develop numerous cellular and biochemical assays for enzymes in diverse classes such as GPCRs, kinases, methyltransferases and glyosyltransferases.
Abstract
Glycosyltransferase enzymes participate in diverse metabolic and regulatory roles by catalyzing the transfer of sugars to protein, lipid and carbohydrate acceptors as well as to other endogenous and xenobiotic molecules. Of more than 200 human glycosyltransferases (GTs), there are over 20 distinct polypeptide N-acetylgalactosaminyltransferases (GALNTs) that catalyze the initial step of O-glycosylation by transferring GalNac to Thr or Ser residues on multiple targets including mucins. Abnormal post-translational glycosylation of mucin is a driver of cancer-associated changes diversely affecting growth and survival of cancer cells and their ability to invade and metastasize. GALNT3 overexpression and dysregulation has been directly linked to multiple cancers including gastric, pancreatic, ovarian, lung and others making it a compelling target for drug discovery. Development of an HTS workflow for GALNT3 is described here. Recombinant First, GALNT3 enzyme activity robustness was first evaluated tested and optimized in the Trasncreener UDP2 Assay with the donor and acceptor substrates UDP-GalNac and Mucin 10 (153-165) EA2 peptide. Second, in order to perform a pilot screen, optimal GALNT3 concentration and Km values for both substrates were determined. Thirdly, A pilot screen was run using the TR-FRET-based assay with a with a diverse, pre-screened filtered 8,000 compound OPS orthogonally pooled compound set library from LCGC from the Lankenau Institute for Medical Research (LIMR) Chemical Genomics Center which allowed screening of 8,000 compounds in duplicate in just five 384-well plates. Hits were confirmed followed by dose-response curves of all potential hits measurements with the primary screening assay and then further validated with a FP based Transcreener UDP2 Assay second assay format. Finally, two confirmed hits were further evaluated for the longevity of target engagement by doing jump dilution performing rapid dilution experiments to assess measure dissociation rates residence time and reversibility.

Seung Yeon Chung
Chung-Ang University, South Korea
Title: Analysis of glycosylation pattern of secretory pathogenesis-associated mannoproteins in the human fungal pathogen Cryptococcus neoformans
Biography
Seung Yeon Chung completed Bachelor of Science at the age of 22 years from Suwon University. I am a graduate student in the master course of molecular biology under the supervision of Professor H. A. Kang at Department of Life Science, Chung-Ang University in Seoul, Korea.
Abstract
The human fungal pathogen Cryptococcus neoformans causes life-threatening meningitis in immunocompromised patients. The virulence of C. neoformans depends on production of a polysaccharide capsule and deposition of melanin in the cell wall along with an ability to secrete various proteins. Secreted phospholipase B1 (PLB1) with high levels of N-linked glycosylation is one of fungal virulence determinants. Several mannoproteins such as chitin deacetylase 2(MP98) are also known as key antigens stimulating T-cell response. Here, we report secretory expression analysis of PLB1 and MP98 by constructing His-tagged and GPI anchorless PLB1 (PLB1-HisGPI-) and MP98 (MP98-HisGPI-) proteins and expressing them in the wild-type and several glycosylation mutant strains of C. neoformans. The apparent molecular weights of PLB1-HisGPI- and MP98-HisGPI- were decreased in the mutant strains such as alg3Δ, mnn2Δ and och1Δ strains respectively which have defects in biosynthesis of N-linked glycans. Unexpectedly, the molecular weight of MP98-HisGPI- secreted from the O-glycosylation mutants was identical to that secreted from the wild type suggesting that ser/thr-rich regions in C-terminus of MP98 might not be O-glycosylated. Moreover, we observed that MP98 was secreted as more heavily glycosylated forms in synthetic complete medium compared to the cultivation with rich medium. The purified mannoproteins with different degree of glycosylation would be valuable tools to investigate the role of glycans assembled on mannoproteins in the interaction of C. neoformans with host cells.